Xiao Xing Jiang
Directeur/Membre du Conseil chez Continent Pharmaceutical Inc.
Profil
Xiao Xing Jiang is the founder of Baoshan Capital, which was founded in 2011.
He held the title of Founding Partner from 2011 to 2014.
Currently, he holds three positions: Non-Executive Director at Continent Pharmaceutical Inc. since 2017, Director at Tilyson Hangzhou Holding Ltd.
since 2017, and Partner at Beijing Ancheng Investment Fund Management Co. Ltd.
Formerly, he was a Director at Chongqing Weiqiao Financial Factoring Co., Ltd.
from 2016 to 2019, a Director at Beijing Continent Pharmaceutical Co., Ltd., and a Director at Zhejiang Zhentai Guarantee Co. Ltd.
from 2015 to 2016.
Mr. Jiang received his undergraduate degree from the University of California in 2004.
Postes actifs de Xiao Xing Jiang
| Sociétés | Poste | Début |
|---|---|---|
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 18/07/2018 |
| Tilyson Hangzhou Holding Ltd. | Directeur/Membre du Conseil | 01/01/2017 |
Beijing Ancheng Investment Fund Management Co. Ltd.
 Beijing Ancheng Investment Fund Management Co. Ltd. Investment ManagersFinance Beijing Ancheng Investment Fund Management Co. Ltd. provides asset management services. The private company is based in Beijing, China. | Corporate Officer/Principal | - |
Anciens postes connus de Xiao Xing Jiang
| Sociétés | Poste | Fin |
|---|---|---|
Chongqing Weiqiao Financial Factoring Co., Ltd.
 Chongqing Weiqiao Financial Factoring Co., Ltd. Financial ConglomeratesFinance Chongqing Weiqiao Financial Factoring Co., Ltd. provides financing, refactoring, customer credit investigation and evaluation services. It also provides payment settlement, management and collection of account receivable; transfer and underwriting of financial accounts receivable assets services. The company was founded on November 22, 2016 and is headquartered in Chongqing, China. | Directeur/Membre du Conseil | 01/02/2019 |
| Zhejiang Zhentai Guarantee Co. Ltd. | Directeur/Membre du Conseil | 01/12/2016 |
| Baoshan Capital | Fondateur | 01/08/2014 |
Beijing Continent Pharmaceutical Co., Ltd.
 Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | - |
Formation de Xiao Xing Jiang
| University of California | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
Chongqing Weiqiao Financial Factoring Co., Ltd.
Chongqing Weiqiao Financial Factoring Co., Ltd. Financial ConglomeratesFinance Chongqing Weiqiao Financial Factoring Co., Ltd. provides financing, refactoring, customer credit investigation and evaluation services. It also provides payment settlement, management and collection of account receivable; transfer and underwriting of financial accounts receivable assets services. The company was founded on November 22, 2016 and is headquartered in Chongqing, China. | Finance |
Beijing Continent Pharmaceutical Co., Ltd.
Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Health Technology |
| Baoshan Capital | |
| Zhejiang Zhentai Guarantee Co. Ltd. | |
| Tilyson Hangzhou Holding Ltd. | |
Beijing Ancheng Investment Fund Management Co. Ltd.
Beijing Ancheng Investment Fund Management Co. Ltd. Investment ManagersFinance Beijing Ancheng Investment Fund Management Co. Ltd. provides asset management services. The private company is based in Beijing, China. | Finance |
